
The U.S. Food and Drug Administration has issued a public health advisory alerting patients and health care providers to make the switch to hydrofluoroalkane (HFA)-propelled albuterol inhalers because chlorofluorocarbon (CFC)-propelled inhalers will no longer be available in the United States after December 31, 2008.